HBcAg Antibody

Product: Sulfaguanidine

HBcAg Antibody Summary

Immunogen
HBcAg purified from the lysate of E.coli infected with the viral core DNA.
Localization
Nuclear
Specificity
This antigen stains the nuclei of liver cells of Hepatitis type B virus infected patients.
However, occasional staining may also be seen in the perinuclear cytoplasm of the infected cells.
Clonality
Polyclonal
Host
Rabbit
Gene
HBVgp4
Purity
IgG purified
Innovators Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.

Learn about the Innovators Reward

Applications/Dilutions

Dilutions
  • Immunohistochemistry 1:10-1:500
  • Immunohistochemistry-Frozen Neat
  • Immunohistochemistry-Paraffin Neat
Application Notes
This antibody has been pretitered and quality controlled to work on formalin-fixed paraffin-embedded as well as acetone fixed cryostat tissue sections. No further titration is required. We suggest an incubation period of 30-60 minutes at room temperature.

Reactivity Notes

This antigen reacts in the nuclei of the liver cells of the Hepatitis type B virus infected patients

Packaging, Storage & Formulations

Storage
Store at 4C. Do not freeze.
Buffer
PBS
Preservative
Sodium Azide
Purity
IgG purified

Notes

This product has a prediluted size available. If a 6mL or 7mL pre-diluted size is purchased this product can be used Neat (without further dilution). Use recommended dilution for the concentrated vials only.

Alternate Names for HBcAg Antibody

  • c
  • Core antigen
  • HBc
  • HBcAg
  • Hepatitis B Virus core antigen

Background

Hepatitis B Virus Core Antigen (HBcAg) is part of the infectious virion containing an inner “core particle” enclosing the viral genome. The icosahedral core particle contains 180 or 240 copies of the core protein. HBcAg is one of the three major clinical antigens of hepatitis B virus but disappears early in the course of infection. The hepatitis B virus core antigen (HBcAg) is a highly immunogenic subviral particle and functions as both a T-cell-dependent and a T-cell-independent antigen. Therefore, HBcAg may be a promising candidate target for therapeutic vaccine control of chronic HBV infection. This antibody stains predominantly the nuclei of liver cells. Occasionally variable staining may also be seen in the perinuclear cytoplasm.

PMID: 1817961